Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Preferred Shares (2019 - 2024)

Historic Preferred Shares for ImmunoTech (AIM) over the last 4 years, with Q1 2024 value amounting to $689000.0.

  • ImmunoTech's Preferred Shares changed N/A to $689000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $689000.0, marking a year-over-year change of. This contributed to the annual value of $689000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that ImmunoTech reported Preferred Shares of $689000.0 as of Q1 2024.
  • ImmunoTech's 5-year Preferred Shares high stood at $769000.0 for Q1 2020, and its period low was $689000.0 during Q4 2023.
  • Its 3-year average for Preferred Shares is $713857.1, with a median of $690000.0 in 2023.
  • Over the last 5 years, ImmunoTech's Preferred Shares had its largest YoY gain of 638.57% in 2020, and its largest YoY loss of 6947.2% in 2020.
  • ImmunoTech's Preferred Shares (Quarter) stood at $733000.0 in 2020, then dropped by 6.0% to $689000.0 in 2023, then changed by 0.0% to $689000.0 in 2024.
  • Its Preferred Shares was $689000.0 in Q1 2024, compared to $689000.0 in Q4 2023 and $690000.0 in Q3 2023.